HGEN News and Press, Humanigen Inc. From 10/31/22

Short Hills, New Jersey--(Newsfile Corp. - October 31, 2022) - Humanigen, Inc. (Nasdaq: HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused on preventing and treating certain inflammatory and oncological conditions, today announced it has engaged SC&H Capital, an affili...

New York, New York--(Newsfile Corp. - September 28, 2022) - Levi & Korsinsky, LLP notifies investors in Humanigen, Inc. ("Humanigen" or the "Company") (NASDAQ: HGEN) of a class action securities lawsuit. The lawsuit on behalf of Humanigen investors has been commenced in the the United S...

Additional Clinical Sites Expected to Enroll CMML Patients in Australia Short Hills, New Jersey and Adelaide, South Australia--(Newsfile Corp. - September 12, 2022) - Humanigen, Inc. (Nasdaq: HGEN), Humanigen Australia Pty Ltd, ("Humanigen") and the South Australian Health and Medical Researc...

Short Hills, New Jersey--(Newsfile Corp. - September 7, 2022) - Humanigen, Inc. (Nasdaq: HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused on developing lenzilumab ("LENZ ® " ), a first-in class antibody that neutralizes granulocyte-macrophage colony-stimulating fac...

Humanigen press release ( NASDAQ: HGEN ): Q2 GAAP EPS of -$0.43 misses by $0.11 . Revenue of $1.04M (flat Y/Y) beats by $0.69M . As of June 30, 2022, the company had cash and cash equivalents of approximately $47.0 million. Shares +1.93% . For fur...

Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on developing lenzilumab (LENZ ® ), a first-in class antibody that neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF), today reported financial resu...

Short Hills, New Jersey--(Newsfile Corp. - July 26, 2022) - Humanigen, Inc. (NASDAQ: HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused on developing lenzilumab, a first-in class antibody that neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF), today ann...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: ventdusud / Shutterstock.com We’re starting off Tuesday with an overview of the biggest pre-market stock movers traders will want to know about! We’ve got reverse stock splits, a hostile takeov...

The release of the latest read on consumer inflation, which showed the June figure jumping 9.1% from last year, put pressure on stock prices on Wednesday. Investors worried that the Federal Reserve would ratchet up its interest rate hikes even more, raising the chances of an eventual recess...

The shares of Humanigen ( NASDAQ: HGEN ) fell ~80% to reach a 52-week low on Wednesday after the clinical-stage biotech announced that its experimental therapy Lenzilumab failed in a trial involving hospitalized COVID-19 patients. Removing the COVID sales for Lenzi...